or
forgot password

    • cancer clinical trials in new port richey, FL

    • PROSTVAC®-VF/TRICOM™ Vaccine for the Treatment of Metastatic Prostate Cancer After Failing Hormone Therapy
    Advanced Research Institute
    New Port Richey, Florida 34652
    Prostate Cancer
    Efficacy and Safety of Nipent, Cytoxan and Rituxan in the Treatment of Chronic Lymphocytic Leukemia.
    Pasco Pinellas Cancer Center

    Trial Locations
    Pasco Pinellas Cancer Center
    Pasco Hernando Oncology Associates, PA
    Chronic Lymphocytic Leukemia
    S-1 as Second-Line Therapy in Treating Patients With Unresectable or Recurrent Stage III or Stage IV Non-Small Cell Lung Cancer
    Florida Cancer Institute - New Port Richey
    New Port Richey, Florida 34655
    Lung Cancer
    S-1 as Second-Line Therapy in Treating Patients With Metastatic Pancreatic Cancer
    Florida Cancer Institute - New Port Richey
    New Port Richey, Florida 34655
    Pancreatic Cancer
    PhII ICb With/Without Erbitux in MBC Pts
    Florida Cancer Institute
    New Port Richey, Florida 34652
    Metastatic Breast Cancer
    Efficacy and Safety of Zoledronic Acid ( Every 4 Weeks vs. Every 12 Weeks) in Patients With Documented Bone Metastases From Bone Cancer
    Pasco Hernando Oncology

    Trial Locations
    Pasco Hernando Oncology
    Pasco Hernando Oncology Associates, PA
    Breast Cancer
    Adj TC + Herceptin Early Stage Breast Cancer
    Florida Cancer Institute
    New Port Richey, Florida 34652
    Breast Cancer
    TAC Versus TC for Adjuvant Breast Cancer
    Florida Cancer Institute
    New Port Richey, Florida 34652
    Breast Cancer
    Phase 2b Study of Taxol Plus Sorafenib or Placebo in Patients With Advanced Breast Cancer
    Pasco Hernando Oncology Associates, PA - New Port Richey
    New Port Richey, Florida 34652
    Breast Cancer
    Mitoxantrone ± Cetuximab 2nd Line Androgen Independent Prostate Cancer (AIPC)
    Florida Cancer Institute - New Hope
    New Port Richey, Florida 34655
    Androgen-independent Prostate Cancer
    Efficacy and Safety of Nilotinib Patients With Newly Diagnosed CML - CP (Chronic Myelogenous Leukemia - Chronic Phase)
    Florida Cancer Institute
    New Port Richey, Florida 34652
    Myelogenous Leukemia, Chronic
    Safety and Exploratory Efficacy of Kanglaite Injection in Pancreatic Cancer
    Pasco Pinellas Cancer Center
    New Port Richey, Florida 34652
    Pancreatic Cancer
    Lume Lung 2 : BIBF 1120 Plus Pemetrexed Compared to Placebo Plus Pemetrexed in 2nd Line Nonsquamous NSCLC
    1199.14.1057 Boehringer Ingelheim Investigational Site
    New Port Richey, Florida
    Carcinoma, Non-Small-Cell Lung
    Gemzar, Cisp, Sunitinib Urothelial Ca
    Florida Cancer Institute - New Hope
    New Port Richey, Florida 34655
    Urothelial Cancer
    Study to Assess the Effectiveness of RCHOP With or Without VELCADE in Previously Untreated Non-Germinal Center B-Cell-like Diffuse Large B-Cell Lymphoma Patients
    Florida Cancer Institute ATI
    New Port Richey, Florida 34655
    Non-Germinal B-Cell-like (GCB) Diffuse Large B-cell Lymphoma (DLBCL)
    Ixabepilone + Carboplatin Metastatic Breast Cancer
    Florida Cancer Institute - New Hope
    New Port Richey, Florida 34655
    Metastatic Breast Cancer
    Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry
    Pasco Hernando Oncology Associates (Kumar)
    New Port Richey, Florida 34652
    Chronic Lymphocytic Leukemia
    Connect® MM- The Multiple Myeloma Disease Registry
    Pasco Hernando Oncology Associates (Kumar)

    Trial Locations
    Pasco Hernando Oncology Associates (Kumar)
    US Oncology - Florida Cancer Institute - New Hope-New Port Richey
    Multiple Myeloma
    Efficacy Study of REOLYSIN® in Combination With Paclitaxel and Carboplatin in Platinum-Refractory Head and Neck Cancers
    Pasco Hernando Oncology Associates, PA
    New Port Richey, Florida 34642
    Carcinoma, Squamous Cell of the Head and Neck
    PALACE 3: Efficacy and Safety Study of Apremilast to Treat Active Psoriatic Arthritis
    Suncoast Clinical Research
    New Port Richey, Florida 34652
    Psoriatic Arthritis
    CMR Rate of Newly Diagnosed CML-CP Patients Treated With Nilotinib
    Pasco Hernando Oncology
    New Port Richey, Florida 34652
    Chronic Myelogenous Leukemia in Chronic Phase
    Phase III Study of Lenalidomide and Dexamethasone With or Without Elotuzumab to Treat Relapsed or Refractory Multiple Myeloma
    Pasco Hernando Oncology Associates, PA
    New Port Richey, Florida 34642
    Multiple Myeloma
    Phase 1 and 2 Study of PX-866 and Cetuximab
    Pasco Pinellas Cancer Center
    New Port Richey, Florida 34652
    Incurable Metastatic Colorectal Carcinoma, Incurable Progressive, Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck
    Safety and Efficacy Pre-Menopausal Women With Heavy Uterine Bleeding and Uterine Fibroids
    Site Reference ID/Investigator# 48163
    New Port Richey, Florida 34652
    Heavy Uterine Bleeding, Uterine Fibroids
    LUX-Lung 8: A Phase III Trial of Afatinib (BIBW 2992) Versus Erlotinib for the Treatment of Squamous Cell Lung Cancer After at Least One Prior Platinum Based Chemotherapy
    1200.125.10081 Boehringer Ingelheim Investigational Site

    Trial Locations
    1200.125.10081 Boehringer Ingelheim Investigational Site
    1200.125.10086 Boehringer Ingelheim Investigational Site
    Carcinoma, Non-Small-Cell Lung
    Triacetyluridine and Fluorouracil Compared With Gemcitabine in Treating Patients With Unresectable Locally Advanced, or Metastatic Pancreatic Cancer
    Florida Cancer Institute - New Port Richey
    New Port Richey, Florida 34655
    Drug/Agent Toxicity by Tissue/Organ, Pancreatic Cancer
    Clinical Trial in Males With BPH (Enlarged Prostate)
    Advanced Research Institute
    New Port Richey, Florida 34652
    Urinary Retention, Prostatic Hyperplasia, Benign Prostatic Hypertrophy
    A Study of Atrasentan in Men With Metastatic, Hormone-Refractory Prostate Cancer
    Advanced Research Institute
    New Port Richey, Florida 34652
    Prostate Cancer
    Study of Atrasentan in Men With Non-Metastatic, Hormone-Refractory Prostate Cancer
    Advanced Research Institute
    New Port Richey, Florida 34652
    Prostatic Neoplasms
    STOP Trial - Sandostatin LAR Depot Trial for the Optimum Prevention of Chemotherapy Induced Diarrhea
    Pasco Hernando Oncology Associates
    New Port Richey, Florida 34652
    Neoplasms, Diarrhea
    Study of a 6-Month Sustained-Release Formulation of Leuprolide Acetate in Prostate Cancer
    Advanced Research Institute
    New Port Richey, Florida 34652
    Prostatic Neoplasms
    Comparative Trial for Pixantrone in Combination With Rituximab in Indolent Non-Hodgkin's Lymphoma
    Pasco, Hernando Oncology Associates, P.A.
    New Port Richey, Florida
    Lymphoma, Follicular, Lymphoma, Mixed-Cell, Follicular, Lymphoma, Small Cleaved-Cell, Follicular, Lymphoma, Low-Grade
    The Effect of Zoledronic Acid on Bone Loss in Prostate Cancer Patients Undergoing Androgen Deprivation Therapy
    Advanced Research Institute, Inc.
    New Port Richey, Florida 34652
    Prostate Cancer
    Satraplatin in Hormone Refractory Prostate Cancer Patients Previously Treated With One Cytotoxic Chemotherapy Regimen
    Florida Cancer Institute
    New Port Richey, Florida 34652
    Prostate Cancer, Hormone Refractory Prostate Cancer
    A Study of ABT-751 in Patients With Renal Cell Cancer
    US Oncology Inc Florida Cancer Institute
    New Port Richey, Florida 34652
    Renal Cell Cancer
    A Study of ABT-751 in Patients With Non-Small Cell Lung Cancer
    Florida Cancer Institute
    New Port Richey, Florida 34652
    Non-Small Cell Lung Cancer
    SDX-105 in Combination With Rituxan for Patients With Relapsed Indolent or Mantle Cell Non-Hodgkin's Lymphoma (NHL)
    Pasco Hernando Oncology
    New Port Richey, Florida 34652
    Non-Hodgkin's Lymphoma
    A Phase III Study of the Efficacy of Taxotere/Aptosyn Versus Taxotere/Placebo in Non-Small Cell Lung Cancer Patients
    Florida Cancer Institute
    New Port Richey, Florida 34652
    Non-Small Cell Lung Cancer
    Gemcitabine/Oxaliplatin (GEMOX) vs Carboplatin/Paclitaxel (CP) in Non-Small Cell Lung Cancer (NSCLC)
    Florida Cancer Institute
    New Port Richey, Florida 34652
    Carcinoma, Non-Small-Cell Lung
    A Study to Evaluate Tarceva in Patients With Advanced Non-Small Cell Lung Cancer (NSCLC)
    Florida Cancer Institute
    New Port Richey, Florida 34652
    Lung Cancer, Non-small-cell Lung Carcinoma
    Study of ABI-007 in Combination With Carboplatin and Herceptin in Patients With Advanced Breast Cancer
    Florida Cancer Institute
    New Port Richey, Florida 34652
    Breast Cancer
    Non-small Cell Lung Cancer Registry
    Pasco Pinellas Cancer Center
    New Port Richey, Florida 34652
    Non-Small-Cell Lung Cancer, Pleural Effusion, Malignant
    Alternative Dosing Regimens of Subcutaneous Azacitidine for Myelodysplastic Syndromes
    Florida Cancer Institute
    New Port Richey, Florida 34652
    Myelodysplastic Syndromes
    A Multiple Myeloma Trial in Patients With Bone Metastases
    Pasco Hernado Oncology
    New Port Richey, Florida 34652
    Multiple Myeloma